Skip to main content

Table 8 Secondary outcome measures

From: Pilot parallel randomised controlled trial of protective socks against usual care to reduce skin tears in high risk people: ‘STOPCUTS’

  Socks group: percent completion, mean and (s.d.) or median and (IQR). N = 44 TAU group: percent completion, mean and (s.d.) or median and (IQR). N = 46
Measure
Completion (%)
Mean (sd)
Median (IQR)
Baseline After injury (n = 10) At 16 weeks Change from baseline to 16 weeks Baseline After injury (n = 13) At 16 weeks Change from baseline to 16 weeks
EQ5D mobility 100% 100% 86.4%   100% 61.9% 89.1%  
3.09 1.25) 3.10 (1.37 2.74 (1.31) − 0.35 2.83 (1.36) 2.38 (1.12) 2.56 (1.31) − 0.27
3.5 (2) 3.5 (2) 3.0 (3) − 0.5 3.0 (2) 2.0 (2) 3.0 (3) 0
EQ5D self-care 100% 100% 84.1%   100% 61.9% 87%  
2.2 (1.44) 1.04 (1.62) 2.05 (1.37) − 0.15 2.46 (1.66) 1.62 (0.87) 2.10 (1.46) − 0.36
2.0 (2) 1.5 (3) 1.0 (2) − 1.0 2.0 (3) 1.0 (2) 1.0 (2) − 1.0
EQ5D usual activities 100% 100% 86.4%   97.8% 61.9% 87%.  
2.64 (1.45) 3.0 (1.70) 2.54 (1.45) − 0.1 2.31 (1.31) 2.08 (1.12) 2.35 (1.44) 0.04
2.0 (3) 3.0 (4) 2.0 (3) 0 2.0 (2) 2.0 (2) 2.0 (2) 0
EQ5D pain/discomfort 100% 100% 86.4%   100% 61.9% 89.1%  
2.14 (1.07) 1.80 (1.03) 1.95 (1.01) − 0.19 1.96 (0.89) 1.38 (0.77) 1.90 (0.94) − 0.06
2.0 (2) 1.5 (1) 2.0 (2) 0 2.0 (2) 1.0 (1) 2.0 (2) 0
EQ5D anxiety/depression 100% 100% 86.4%   97.8% 61.9% 89.1%  
1.3 (0.63) 1.3 (0.48) 1.50 (0.76) 0.2 1.57 (0.86) 1.31 (0.48) 1.41 (0.81) − 0.16
1.0 (0) 1.0 (1) 1.0 (1) 0 1.0 (1) 1.0 (1) 1.0 (1) 0
EQ5D utility score 100% 100% 84.1%   95.7% 61.9% 87%  
0.664 (0.234) 0.649 (0.204) 0.695 (0.227) 0.031 0.673 (0.262) 0.808 (0.186) 0.731 (0.246) 0.058
EQ5D health state 84.1% 60% 65.9%   87% 52.4% 65.2%  
62.62 (21.45) 63.33 (12.52) 68.66 (17.01) 6.04 67.58 (23.35) 71.45 (22.05) 69.77 (22.03) 2.19
EQ5D health state box 90.9% 90% 81.8%   91.3% 61.9% 82.6%  
62.63 (21.56) 64.44 (12.36) 71.53 (20.18) 8.9 67.50 (23.12) 73.08 (21.07) 70.13 (21.2) 2.63
ICECAP 100% 100% 100%   86.4% 61.9% 89.1%  
0.737 (0.419) 0.6359 (0.2514) 0.811 (0.285) 0.074 0.767 (0.310) 0.7107 (0.2395) 0.788 (0.309) 0.021
FES 100% 100% 86.4%   100% 61.9% 89.1%  
14.25 (6.16) 14.7 (5.27) 14.24 (6.31)   12.98 (5.44) 14.08 (6.78) 13.29 (6.52)  
13 (8.5) 14 (10.5) 14 (10.25) 1 11(6) 11 (11) 10 (10) − 1.0
CWIS physical symptoms and daily living/120 N/a 100% 50%   N/a 61.9% 70%  
N/a 28.7 (14.85) 26.25 (4.5) − 2.45 N/a 26.62 (9.2) 32.0 (8.35) 5.38
N/a 24.5 (18) 24 (6.8) − 0.5 N/a 28 (12.5) 30 (4) 2.0
CWIS social life/70 N/a 100% 50%   N/a 61.9% 70%  
N/a 15.8 (13.59) 15.0 (2.0) − 0.8 N/a 15.54 (5.75) 18.0 (6.51) 2.46
N/a 7.5 (18.75) 14 (3) 6.5 N/a 15 (4.5) 15 (6) 0
CWIS wellbeing/35 (high score is worse) N/a 90% 75%   N/a 61.9% 70%  
N/a 11.26 (4.73) 10.67 (4.32) − 0.59 N/a 15.84 (4.45) 17.14 (5.15) 1.3
N/a 15 (7) 9.5 (7.25) − 5.5 N/a 17 (8) 18 (5) 1.0
CWIS quality of life/20 (high score is better) N/a 100% 62.5%   N/a 61.9% 70%  
N/a 13.5 (3.95) 11.8 (4.03) − 1.7 N/a 15.15 (3.21) 12.43 (6.19) − 2.72
N/a 14.5 (3.5) 14 (8) − 0.5 N/a 16 (5.5) 14 (13) − 2.0